These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 12567295)
1. What is optimal antimicrobial therapy for bacteremic pneumococcal pneumonia? File TM; Mandell LA Clin Infect Dis; 2003 Feb; 36(4):396-8. PubMed ID: 12567295 [No Abstract] [Full Text] [Related]
2. Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia. Martínez JA; Horcajada JP; Almela M; Marco F; Soriano A; García E; Marco MA; Torres A; Mensa J Clin Infect Dis; 2003 Feb; 36(4):389-95. PubMed ID: 12567294 [TBL] [Abstract][Full Text] [Related]
3. A comparative study of bacteremic and non-bacteremic pneumococcal pneumonia. Jover F; Cuadrado JM; Andreu L; Martínez S; Cañizares R; de la Tabla VO; Martin C; Roig P; Merino J Eur J Intern Med; 2008 Jan; 19(1):15-21. PubMed ID: 18206596 [TBL] [Abstract][Full Text] [Related]
4. Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin. Fogarty C; Goldschmidt R; Bush K Clin Infect Dis; 2000 Aug; 31(2):613-5. PubMed ID: 10987733 [TBL] [Abstract][Full Text] [Related]
5. Severe pneumococcal pneumonia: new strategies for management. Chiou CC; Yu VL Curr Opin Crit Care; 2006 Oct; 12(5):470-6. PubMed ID: 16943728 [TBL] [Abstract][Full Text] [Related]
6. In vitro activity of ertapenem against bacteraemic pneumococci: report of a French multicentre study including 339 strains. Decousser JW; Methlouthi I; Pina P; Allouch P; J Antimicrob Chemother; 2005 Mar; 55(3):396-8. PubMed ID: 15705639 [No Abstract] [Full Text] [Related]
8. A testament to sustained macrolide efficacy. Bishai W Clin Infect Dis; 2003 Apr; 36(7):935-6; author reply 936-7. PubMed ID: 12652400 [No Abstract] [Full Text] [Related]
9. Addition of a macrolide to a ss-lactam in bacteremic pneumococcal pneumonia. Dwyer R; Ortqvist A; Aufwerber E; Henriques Normark B; Marrie TJ; Mufson MA; Torres A; Woodhead MA; Alenius M; Kalin M Eur J Clin Microbiol Infect Dis; 2006 Aug; 25(8):518-21. PubMed ID: 16896822 [TBL] [Abstract][Full Text] [Related]
10. [New quinolones for the treatment of community-acquired pneumonia--contra]. Egger M Dtsch Med Wochenschr; 2003 May; 128(19):1071. PubMed ID: 12736860 [No Abstract] [Full Text] [Related]
11. Re-evaluation of the therapy of severe pneumonia caused by Streptococcus pneumoniae. Plouffe JF; Martin DR Infect Dis Clin North Am; 2004 Dec; 18(4):963-74; x-xi. PubMed ID: 15555834 [TBL] [Abstract][Full Text] [Related]
14. [Utility of blood cultures on antibiotic therapy in adult bacteremic pneumococcal pneumonia]. Mathurin L S; Agüero L A; Jaimet A C; Schälibaum G E; Demergasso S M; Acuña S V Rev Chilena Infectol; 2009 Feb; 26(1):9-17. PubMed ID: 19350153 [TBL] [Abstract][Full Text] [Related]
19. Emergence of macrolide resistance during treatment of pneumococcal pneumonia. Musher DM; Dowell ME; Shortridge VD; Flamm RK; Jorgensen JH; Le Magueres P; Krause KL N Engl J Med; 2002 Feb; 346(8):630-1. PubMed ID: 11856810 [No Abstract] [Full Text] [Related]
20. Pneumococcal pneumonia in adults treated at University of Kentucky Medical Center, 1995-1998: implications of pathogen resistance. Greenberg RN; Martin E Clin Infect Dis; 1999 May; 28(5):1160-2. PubMed ID: 10452654 [No Abstract] [Full Text] [Related] [Next] [New Search]